* AtriCure Inc ATRC.OQ reported a quarterly adjusted loss
of 11
cents per share for the quarter ended in June. The mean
expectation of seven analysts for the quarter was for a loss
of 30 cents per share.
* Revenue rose 19.4% to $100.92 million from a year ago;
analysts
expected $97.49 million.
* AtriCure Inc's reported EPS for the quarter was a loss
of 11
cents.
* The mean earnings estimate of analysts had risen by
about 7.6%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* AtriCure Inc shares had risen by 8.1% this quarter and
gained 20.2% so far this year.
* The company reported a quarterly loss of $5.12 million.
* Wall Street's median 12-month price target for AtriCure
Inc is
$55.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data July
25 at 10:01 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2023 -0.30 -0.11 Beat
Mar. 31 2023 -0.34 -0.23 Beat
Dec. 31 2022 -0.18 -0.09 Beat
Sep. 30 2022 -0.25 -0.27 Missed